Juventus Faces Double Injury Blow: Khephren Thuram to Undergo Surgery, Nick Woltemade and Pape Sarr Arrive

Juventus midfielder Khephren Thuram is slated for knee surgery on Thursday, September 3rd. Reports from multiple Italian outlets indicate an expected four-month recovery period, potentially keeping him sidelined until January 2027.

Coinciding with this news, Juventus has finalized a season-long loan agreement for Newcastle United forward Nick Woltemade.

While these two events occurred close together, the club's injury update and transfer news highlight separate squad challenges rather than a direct cause-and-effect transaction.

Thuram's Knee Surgery

Thuram has been managing patellofemoral syndrome since the conclusion of the 2025-26 season. Earlier this week, he consulted with knee specialist Bertrand Sonnery Cottet in Lyon, which preceded the recommendation for surgery.

According to Gazzetta, the arthroscopic procedure will address wear and tear of the cartilage behind the kneecap, a detail derived from specialist assessment rather than an official club statement.

Thuram did not participate in any Juventus pre-season friendlies and largely trained separately from the squad over the summer, consistent with a developing issue.

In response to Thuram's situation, Juventus secured the loan of Pape Matar Sarr from Tottenham on deadline day. The deal reportedly includes an obligation to buy for €27.5 million if certain season conditions are met. The loan fee itself is estimated to be around €2.5 million.

This acquisition is intended to bolster midfield depth, specifically to cover for Thuram during the initial months of the campaign. This signing aligns with the club's broader reinforcement strategy, as previously discussed in relation to Juventus' midfield options amidst squad limitations.

Further compounding the club's early-season absentee list, reports also indicate that Kenan Yildiz has undergone foot fracture surgery and is expected to be out for at least three months.

Woltemade Joins from Newcastle on Loan

In a separate development, Juventus reached an agreement with Newcastle for Nick Woltemade on a dry loan. Gianluca Di Marzio reported that Woltemade had approved the transfer and was scheduled to travel to Italy for his medical examination.

This deal addresses an attacking need for Juventus, rather than a midfield one. It follows Jonathan David's loan departure to Atletico Madrid, a deal that includes a €25 million buy option, a context also relevant to Juventus' prior search for attacking reinforcements.

Earlier in the transfer window, Juventus had also been in discussions with Manchester United regarding Joshua Zirkzee. Reports suggest Woltemade was ultimately favored due to his lower cost and the absence of an obligation-to-buy clause that Manchester United sought for Zirkzee.

The 24-year-old German international made 53 appearances for Newcastle across all competitions last season, scoring 11 goals and providing six assists.

Juventus has confirmed the deal as a season-long loan set to run until June 2027, with no purchase option or obligation attached—a straightforward arrangement distinct from the Sarr deal.

Strategic Squad Replacements

The two signings address distinct areas of concern. Sarr was brought in to provide midfield cover during Thuram's lengthy absence. Woltemade, who can operate as a central striker or a deeper No. 10, was acquired to strengthen the attack following David's move to Atletico.

There is no indication in the available reports that Woltemade is considered a direct replacement for the injured midfielder.

Woltemade's career trajectory has been notable: he developed through the youth ranks at Werder Bremen, had a loan spell at SV Elversberg, and then moved to Stuttgart in 2024, where he reportedly scored 18 goals in 36 appearances and won the German Cup. This impressive form led to Newcastle's club-record move a year ago. Now, standing at 1.98 meters, he is switching leagues again in search of a more consistent role.

Outlook for Thuram, Woltemade, and Sarr

The immediate priority is Thuram's surgery on Thursday, with his return targeted for January 2027, pending a successful recovery.

Sarr's arrival provides the midfield cover explicitly mentioned in the injury report. Woltemade's medical and loan paperwork appear to have been finalized around the September 1st announcement.

Any further tactical adjustments or the potential for a permanent move for Woltemade remain unconfirmed by current available evidence.